|
Market Closed -
Canadian Securities Exchange
12:43:47 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -20.00% |
| Market Cap | 5.21M 3.76M 3.24M 3.05M 2.78M 355M 5.22M 36.01M 13.97M 182M 14.13M 13.83M 587M | P/E 2024 |
-4.18x | P/E 2025 | -22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 22.27M 16.09M 13.85M 13.03M 11.9M 1.52B 22.33M 154M 59.74M 780M 60.43M 59.11M 2.51B | EV / Sales 2024 |
1.1x | EV / Sales 2025 | 1.26x |
| Free-Float |
86.8% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| QF | Delayed | |
OTC Markets
| TGIFF | Delayed |
| 1 month | +100.00% | ||
| 3 months | +100.00% | ||
| Current year | -20.00% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0 | 0.02 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.02 | |
| 3 years | 0 | 0.03 | |
| 5 years | 0 | 0.09 | |
| 10 years | 0 | 1.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Farrell
CEO | Chief Executive Officer | - | 2025-01-31 |
Jeremy Fong
DFI | Director of Finance/CFO | 34 | 2025-01-31 |
Ester Vigil
PSD | President | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Farrell
CHM | Chairman | - | 2025-01-31 |
Paul Rosen
CHM | Chairman | 62 | 2021-01-28 |
Curtis Floyd
BRD | Director/Board Member | - | 2023-06-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/1/25 | Option | Investor Relations Manager | 200,000 | 0.0408% | ||
| 12/1/25 | Option | Company Secretary | 100,000 | 0.0204% | ||
| 9/22/25 | Buy | Chief Executive Officer | 2,000,000 | 0.4078% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -33.33% | 3.76M | ||
| +4.10% | +2.01% | +14.91% | -23.39% | 2.63B | ||
| 0.00% | +18.64% | -12.94% | +138.10% | 618M | ||
| 0.00% | -3.64% | -7.02% | -11.67% | 58.53M | ||
| Average | +1.02% | +4.25% | -1.26% | +17.43% | 826.46M | |
| Weighted average by Cap. | +3.26% | +5.01% | +9.30% | +6.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 19.35M 13.99M 12.04M 11.32M 10.34M 1.32B 19.4M 134M 51.92M 678M 52.52M 51.38M 2.18B | 17.45M 12.61M 10.85M 10.21M 9.33M 1.19B 17.49M 121M 46.81M 611M 47.35M 46.32M 1.97B |
| Net income | -1.14M -825K -710K -668K -610K -77.93M -1.15M -7.9M -3.06M -39.99M -3.1M -3.03M -129M | -217K -157K -135K -127K -116K -14.81M -218K -1.5M -582K -7.6M -589K -576K -24.48M |
| Net Debt | 16.33M 11.8M 10.15M 9.55M 8.73M 1.11B 16.37M 113M 43.81M 572M 44.31M 43.35M 1.84B | 17.06M 12.33M 10.61M 9.98M 9.12M 1.16B 17.1M 118M 45.77M 597M 46.3M 45.29M 1.92B |
Employees
85
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | $0.0100 | 0.00% | 10,000 |
| 26-09-03 | $0.0100 | 0.00% | 12,000 |
| 26-09-02 | $0.0100 | 0.00% | 55,000 |
| 26-09-01 | $0.0100 | 0.00% | 21,500 |
| 26-08-31 | $0.0100 | 0.00% | 49,333 |
- Stock Market
- Stocks
- QF Stock
Select your edition
All financial news and data tailored to specific country editions

















